Alexander Eggermont, MD, PhD, is currently Professor of Immunotherapy at the University Medical Center Utrecht in the Netherlands, Scientific Director of the Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands and Board Member of the Comprehensive Cancer Center Munich between the Technical University Munich and the Ludwig Maximiliaan University, Munich, Germany.
He is the past Directeur Général of the Gustave Roussy Cancer Institute (2010-2019) and Professeur Oncologie «Classe Exceptionelle», at the Université Paris-Saclay (2012-2020). He was head of Department of Oncological Surgery at the Erasmus University of Rotterdam, Netherlands 2003-2017. He also holds the Joseph Maisin Honorary Chair of Oncological Surgery at the Louvain Catholic University (Belgium). He is a Melanoma, Soft tissue sarcoma and Immunotherapy specialist and Fellow of the NIH-NCI Surgery Branch (Chief Steve Rosenberg). During his career, he was o.a. President of the the EORTC (European Organization for Research and Treatment of Cancer) from 2003 to 2006 and President of ECCO (European CanCer Organization) from 2008 to 2010, and President of the of the European Academy of Cancer Sciences (2011-2019).